Work

AI-Driven Tablet Manufacturing

Year: 2026
Type: article
Abstract: Artificial Intelligence (AI) is rapidly optimising pharmaceutical formulation by enabling more precise, faster and cost-efficient drug formulation processes. Integration of AI technologies (such as machine learning and deep learning) with pharmaceutical formulation is commonly applied in drug formulation, including artificial neural networks (ANN) and logic systems. The integration of AI with formulation can predict drug behaviour, select excipients for optimisation, and design safer and more efficient dosage forms compared to traditional methods. AI-enabled instruments are currently employed across the pharmaceutical industry, in areas such as formulation optimisation, QC, and stability testing. Adoption of AI results in improved efficiency with data-driven decision-making and the ability to handle complex, multi-variable formulation problems; on the other hand, notable disadvantages such as high implementation costs, dependency on quality data, regulatory challenges, and the need for specialised technical expertise are observed. AI in pharmaceutical formulation has a wide scope in future, as it has the potential to revolutionise the production of medicine, accelerate novel drug delivery system design, and regulatory compliance processes. As AI continues to evolve, its role in pharmaceutical sciences is expected to expand significantly, bridging the gap between computational innovation and practical drug manufacturing, ultimately contributing to safer, more effective, and more accessible pharmaceutical products. This study comprises a detailed review of the application of artificial intelligence in pharmaceutical formulations, including the integration of existing technology with artificial intelligence.
Language: English
Subfield: Drug Discovery
Open Access status: green
OpenAlex ID: W7236673497
FWCI:
Cites:
Cited by:
Related to: 10